<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kubala SA</submitter><funding>Intramural NIH HHS</funding><pagination>109182</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9756444</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>245</volume><pubmed_abstract>Newborn screening (NBS) for severe combined immunodeficiency (SCID) can identify infants with non-SCID T cell lymphopenia (TCL). The purpose of this study was to characterize the natural history and genetic findings of infants with non-SCID TCL identified on NBS. We analyzed data from 80 infants with non-SCID TCL in the mid-Atlantic region between 2012 and 2019. 66 patients underwent genetic testing and 41 (51%) had identified genetic variant(s). The most common genetic variants were thymic defects (33%), defects with unknown mechanisms (12%) and bone marrow production defects (5%). The genetic cohort had significantly lower median initial CD3+, CD4+, CD8+ and CD4/CD45RA+ T cell counts compared to the non-genetic cohort. Thirty-six (45%) had either viral, bacterial, or fungal infection; on</pubmed_abstract><journal>Clinical immunology (Orlando, Fla.)</journal><pubmed_title>Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen.</pubmed_title><pmcid>PMC9756444</pmcid><funding_grant_id>Z99 AI999999</funding_grant_id><pubmed_authors>Keller MD</pubmed_authors><pubmed_authors>Lederman H</pubmed_authors><pubmed_authors>Heimall J</pubmed_authors><pubmed_authors>Lawrence MG</pubmed_authors><pubmed_authors>Anzabi M</pubmed_authors><pubmed_authors>Palacios-Kibler T</pubmed_authors><pubmed_authors>Younger MEM</pubmed_authors><pubmed_authors>Kubala SA</pubmed_authors><pubmed_authors>Ford MK</pubmed_authors><pubmed_authors>DeFelice ML</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Sandhu A</pubmed_authors><pubmed_authors>Harmon G</pubmed_authors><pubmed_authors>Bundy V</pubmed_authors><pubmed_authors>Ward B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen.</name><description>Newborn screening (NBS) for severe combined immunodeficiency (SCID) can identify infants with non-SCID T cell lymphopenia (TCL). The purpose of this study was to characterize the natural history and genetic findings of infants with non-SCID TCL identified on NBS. We analyzed data from 80 infants with non-SCID TCL in the mid-Atlantic region between 2012 and 2019. 66 patients underwent genetic testing and 41 (51%) had identified genetic variant(s). The most common genetic variants were thymic defects (33%), defects with unknown mechanisms (12%) and bone marrow production defects (5%). The genetic cohort had significantly lower median initial CD3+, CD4+, CD8+ and CD4/CD45RA+ T cell counts compared to the non-genetic cohort. Thirty-six (45%) had either viral, bacterial, or fungal infection; on</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-22T13:12:07.196Z</modification><creation>2025-04-06T00:35:29.041Z</creation></dates><accession>S-EPMC9756444</accession><cross_references><pubmed>36368643</pubmed><doi>10.1016/j.clim.2022.109182</doi></cross_references></HashMap>